Inpharma Weekly

, Volume 1037, Issue 1, pp 17–17 | Cite as

Botulinum toxin superior to trihexyphenidyl in dystonia

Newsletter Article

Keywords

Dystonia Botulinum Toxin Primary Outcome Measure Secondary Outcome Measure Severe Adverse Effect 

Copyright information

© Adis International Ltd 1996

Personalised recommendations